Pros and cons of continous glucose monitoring

Authors

DOI:

https://doi.org/10.20883/medical.e873

Keywords:

Continuous glucose monitoring (CGM), Blood glucose monitroing, Diabetes mellitus, MARD, HbA1c

Abstract

Introduction. Diabetes mellitus is a metabolic disorder that might result in short and long-term health complications and even death if not properly managed. This disease affected 451 million people in 2017 worldwide and these figures are expected to increase to 693 million by 2045. Currently, there is no cure for diabetes. However, self-management, especially keeping BG in the recommended range, is crucial to the treatment.
Aim. The aim of this paper is to offer an overview of current literature regarding CGM technologies. We outline mechanism of action, current use of CGM and discuss pros and cons of using this method in DM management.
Material and methods. A review of the literature available in PubMed and Google Scholar databases was conducted.
Results and conclusions. Blood glucose measurement using a glucometer is an invasive method, not very comfortable for the patient, it detects only one temporary blood glucose level. This method does not reflect glucose fluctuations and trends, which makes effective diabetes management difficult. Even supplementing this method with HbA1c measurement does not bring as much relevant information for making therapeutic decision as CGM. The abundance of data provided by CGM and the ability to analyze them in greater detail, provide additional information to help achieve glycemic goals. It is a discreet and minimally invasive method, and the reading of blood glucose values can be easily read from mobile device. Data storage allows the doctor to view the past course of the disease and modify treatment. Manufacturers are constantly improving their devices, eliminating flaws, and the benefits of CGM improve treatment outcomes, which should translate into a reduction in the long-term complications of diabetes. Further research is needed, leading to the development of CGM technology.

Downloads

Download data is not yet available.

References

Woldaregay AZ, Årsand E, Walderhaug S, Albers D, Mamykina L, Botsis T, Hartvigsen G. Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes. Artif Intell Med. 2019 Jul;98:109-134. doi: 10.1016/j.artmed.2019.07.007. Epub 2019 Jul 26. PMID: 31383477.

Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018 Apr;138:271-281. doi: 10.1016/j.diabres.2018.02.023. Epub 2018 Feb 26. PMID: 29496507.

Freckmann G, Pleus S, Grady M, Setford S, Levy B. Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices. J Diabetes Sci Technol. 2019 May;13(3):575-583. doi: 10.1177/1932296818812062. Epub 2018 Nov 19. PMID: 30453761; PMCID: PMC6501529.

Chen C, Zhao XL, Li ZH, Zhu ZG, Qian SH, Flewitt AJ. Current and Emerging Technology for Continuous Glucose Monitoring. Sensors (Basel). 2017 Jan 19;17(1):182. doi: 10.3390/s17010182. PMID: 28106820; PMCID: PMC5298755.

Cappon G, Vettoretti M, Sparacino G, Facchinetti A. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications. Diabetes Metab J. 2019 Aug;43(4):383-397. doi: 10.4093/dmj.2019.0121. PMID: 31441246; PMCID: PMC6712232.

Sun MT, Li IC, Lin WS, Lin GM. Pros and cons of continuous glucose monitoring in the intensive care unit. World J Clin Cases. 2021 Oct 16;9(29):8666-8670. doi: 10.12998/wjcc.v9.i29.8666. PMID: 34734045; PMCID: PMC8546806.

Damiano ER, McKeon K, El-Khatib FH, Zheng H, Nathan DM, Russell SJ. A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and Enlite. J Diabetes Sci Technol. 2014 Jul;8(4):699-708. doi: 10.1177/1932296814532203. Epub 2014 Apr 21. PMID: 24876423; PMCID: PMC4764229.

Freckmann, Guido. "Basics and use of continuous glucose monitoring (CGM) in diabetes therapy" Journal of Laboratory Medicine, vol. 44, no. 2, 2020, pp. 71-79. https://doi.org/10.1515/labmed-2019-0189

Rodbard D. Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. Diabetes Technol Ther. 2016 Feb;18 Suppl 2(Suppl 2):S3-S13. doi: 10.1089/dia.2015.0417. PMID: 26784127; PMCID: PMC4717493.

Kovatchev BP, Patek SD, Ortiz EA, Breton MD. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. Diabetes Technol Ther. 2015 Mar;17(3):177-86. doi: 10.1089/dia.2014.0272. Epub 2014 Dec 1. PMID: 25436913; PMCID: PMC4346608.

Pleus S, Schoemaker M, Morgenstern K, Schmelzeisen-Redeker G, Haug C, Link M, Zschornack E, Freckmann G. Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings. J Diabetes Sci Technol. 2015 Jul;9(4):801-7. doi: 10.1177/1932296815578716. Epub 2015 Apr 7. PMID: 25852074; PMCID: PMC4525645.

Welsh JB, Kaufman FR, Lee SW. Accuracy of the Sof-sensor glucose sensor with the iPro calibration algorithm. J Diabetes Sci Technol. 2012 Mar 1;6(2):475-6. doi: 10.1177/193229681200600237. PMID: 22538161; PMCID: PMC3380794.

Rodbard D. Characterizing accuracy and precision of glucose sensors and meters. J Diabetes Sci Technol. 2014 Sep;8(5):980-5. doi: 10.1177/1932296814541810. Epub 2014 Jul 18. PMID: 25037194; PMCID: PMC4455380.

Heinemann L, Schoemaker M, Schmelzeisen-Redecker G, Hinzmann R, Kassab A, Freckmann G, Reiterer F, Del Re L. Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space. J Diabetes Sci Technol. 2020 Jan;14(1):135-150. doi: 10.1177/1932296819855670. Epub 2019 Jun 19. PMID: 31216870; PMCID: PMC7189145.

Rodbard D. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. Diabetes Technol Ther. 2017 Jun;19(S3):S25-S37. doi: 10.1089/dia.2017.0035. PMID: 28585879; PMCID: PMC5467105.

Kovatchev BP. Hypoglycemia Reduction and Accuracy of Continuous Glucose Monitoring. Diabetes Technol Ther. 2015 Aug;17(8):530-3. doi: 10.1089/dia.2015.0144. Epub 2015 May 15. PMID: 25978096; PMCID: PMC4529100.

Garg SK, Kipnes M, Castorino K, Bailey TS, Akturk HK, Welsh JB, Christiansen MP, Balo AK, Brown SA, Reid JL, Beck SE. Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. Diabetes Technol Ther. 2022 Jun;24(6):373-380. doi: 10.1089/dia.2022.0011. Epub 2022 Feb 21. PMID: 35157505; PMCID: PMC9208857.

Alva S, Bailey T, Brazg R, Budiman ES, Castorino K, Christiansen MP, Forlenza G, Kipnes M, Liljenquist DR, Liu H. Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes. J Diabetes Sci Technol. 2022 Jan;16(1):70-77. doi: 10.1177/1932296820958754. Epub 2020 Sep 19. PMID: 32954812; PMCID: PMC8875061.

Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, Buckingham BA, Carroll J, Ceriello A, Chow E, Choudhary P, Close K, Danne T, Dutta S, Gabbay R, Garg S, Heverly J, Hirsch IB, Kader T, Kenney J, Kovatchev B, Laffel L, Maahs D, Mathieu C, Mauricio D, Nimri R, Nishimura R, Scharf M, Del Prato S, Renard E, Rosenstock J, Saboo B, Ueki K, Umpierrez GE, Weinzimer SA, Phillip M. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57. doi: 10.1016/S2213-8587(22)00319-9. Epub 2022 Dec 6. PMID: 36493795.

Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Bally L, Beck RW, Biester S, Biester T, Blanchette JE, Bosi E, Boughton CK, Breton MD, Brown SA, Buckingham BA, Cai A, Carlson AL, Castle JR, Choudhary P, Close KL, Cobelli C, Criego AB, Davis E, de Beaufort C, de Bock MI, DeSalvo DJ, DeVries JH, Dovc K, Doyle FJ, Ekhlaspour L, Shvalb NF, Forlenza GP, Gallen G, Garg SK, Gershenoff DC, Gonder-Frederick LA, Haidar A, Hartnell S, Heinemann L, Heller S, Hirsch IB, Hood KK, Isaacs D, Klonoff DC, Kordonouri O, Kowalski A, Laffel L, Lawton J, Lal RA, Leelarathna L, Maahs DM, Murphy HR, Nørgaard K, O'Neal D, Oser S, Oser T, Renard E, Riddell MC, Rodbard D, Russell SJ, Schatz DA, Shah VN, Sherr JL, Simonson GD, Wadwa RP, Ward C, Weinzimer SA, Wilmot EG, Battelino T. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice. Endocr Rev. 2023 Mar 4;44(2):254-280. doi: 10.1210/endrev/bnac022. PMID: 36066457; PMCID: PMC9985411.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. PMID: 31177185; PMCID: PMC6973648.

Ólafsdóttir AF, Polonsky W, Bolinder J, Hirsch IB, Dahlqvist S, Wedel H, Nyström T, Wijkman M, Schwarcz E, Hellman J, Heise T, Lind M. A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3). Diabetes Technol Ther. 2018 Apr;20(4):274-284. doi: 10.1089/dia.2017.0363. Epub 2018 Apr 2. PMID: 29608107; PMCID: PMC5910048.

Choudhary P, Amiel SA. Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology. Diabetologia. 2018 Apr;61(4):761-769. doi: 10.1007/s00125-018-4566-6. Epub 2018 Feb 8. PMID: 29423581; PMCID: PMC6448988.

Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial. Diabetes Ther. 2017 Feb;8(1):55-73. doi: 10.1007/s13300-016-0223-6. Epub 2016 Dec 20. PMID: 28000140; PMCID: PMC5306122.

Aleppo G, Laffel LM, Ahmann AJ, Hirsch IB, Kruger DF, Peters A, Weinstock RS, Harris DR. A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes. J Endocr Soc. 2017 Nov 20;1(12):1445-1460. doi: 10.1210/js.2017-00388. PMID: 29344577; PMCID: PMC5760210.

Laffel LM, Aleppo G, Buckingham BA, Forlenza GP, Rasbach LE, Tsalikian E, Weinzimer SA, Harris DR. A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes. J Endocr Soc. 2017 Nov 20;1(12):1461-1476. doi: 10.1210/js.2017-00389. PMID: 29344578; PMCID: PMC5760209.

Kudva YC, Ahmann AJ, Bergenstal RM, Gavin JR 3rd, Kruger DF, Midyett LK, Miller E, Harris DR. Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults. J Endocr Soc. 2018 Nov 14;2(12):1320-1337. doi: 10.1210/js.2018-00294. PMID: 30474069; PMCID: PMC6243139.

Al Hayek AA, Al Dawish MA. Assessing Diabetes Distress and Sleep Quality in Young Adults with Type 1 Diabetes Using FreeStyle Libre: A Prospective Cohort Study. Diabetes Ther. 2020 Jul;11(7):1551-1562. doi: 10.1007/s13300-020-00849-3. Epub 2020 Jun 4. PMID: 32495021; PMCID: PMC7324459.

Hilliard ME, Levy W, Anderson BJ, Whitehouse AL, Commissariat PV, Harrington KR, Laffel LM, Miller KM, Van Name M, Tamborlane WV, DeSalvo DJ, DiMeglio LA. Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. Diabetes Technol Ther. 2019 Sep;21(9):493-498. doi: 10.1089/dia.2019.0142. Epub 2019 Jul 9. PMID: 31287721; PMCID: PMC6708264.

Pickup JC, Ford Holloway M, Samsi K. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives. Diabetes Care. 2015 Apr;38(4):544-50. doi: 10.2337/dc14-1855. Epub 2014 Dec 31. PMID: 25552422.

Shivers JP, Mackowiak L, Anhalt H, Zisser H. "Turn it off!": diabetes device alarm fatigue considerations for the present and the future. J Diabetes Sci Technol. 2013 May 1;7(3):789-94. doi: 10.1177/193229681300700324. PMID: 23759412; PMCID: PMC3869147.

Messer, L. H., et al. "Best friend or spy: a qualitative meta‐synthesis on the impact of continuous glucose monitoring on life with type 1 diabetes." Diabetic Medicine 35.4 (2018): 409-418.

Sinisterra M, Hamburger S, Tully C, Hamburger E, Jaser S, Streisand R. Young Children with Type 1 Diabetes: Sleep, Health-Related Quality of Life, and Continuous Glucose Monitor Use. Diabetes Technol Ther. 2020 Aug;22(8):639-642. doi: 10.1089/dia.2019.0437. Epub 2020 Mar 2. PMID: 32027177; PMCID: PMC7406998.

Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, Brazg RL, Ilany J, Slover RH, Anderson SM, Bergenstal RM, Grosman B, Roy A, Cordero TL, Shin J, Lee SW, Kaufman FR. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2017 Mar;19(3):155-163. doi: 10.1089/dia.2016.0421. Epub 2017 Jan 30. PMID: 28134564; PMCID: PMC5359676.

Forlenza GP, Ekhlaspour L, Breton M, Maahs DM, Wadwa RP, DeBoer M, Messer LH, Town M, Pinnata J, Kruse G, Buckingham BA, Cherñavvsky D. Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial. Diabetes Technol Ther. 2019 Apr;21(4):159-169. doi: 10.1089/dia.2019.0011. Epub 2019 Mar 19. PMID: 30888835; PMCID: PMC6909715.

Forlenza GP, Pinhas-Hamiel O, Liljenquist DR, Shulman DI, Bailey TS, Bode BW, Wood MA, Buckingham BA, Kaiserman KB, Shin J, Huang S, Lee SW, Kaufman FR. Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes. Diabetes Technol Ther. 2019 Jan;21(1):11-19. doi: 10.1089/dia.2018.0264. Epub 2018 Dec 26. PMID: 30585770; PMCID: PMC6350071.

Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW; iDCL Trial Research Group. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. N Engl J Med. 2019 Oct 31;381(18):1707-1717. doi: 10.1056/NEJMoa1907863. Epub 2019 Oct 16. PMID: 31618560; PMCID: PMC7076915.

Bisio A, Gonder-Frederick L, McFadden R, Cherñavvsky D, Voelmle M, Pajewski M, Yu P, Bonner H, Brown SA. The Impact of a Recently Approved Automated Insulin Delivery System on Glycemic, Sleep, and Psychosocial Outcomes in Older Adults With Type 1 Diabetes: A Pilot Study. J Diabetes Sci Technol. 2022 May;16(3):663-669. doi: 10.1177/1932296820986879. Epub 2021 Jan 15. PMID: 33451264; PMCID: PMC9294584.

Cobry EC, Hamburger E, Jaser SS. Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents. Diabetes Technol Ther. 2020 Nov;22(11):794-800. doi: 10.1089/dia.2020.0057. Epub 2020 Oct 13. PMID: 32212971; PMCID: PMC7698988.

Bisio A, Brown SA, McFadden R, Pajewski M, Yu PL, DeBoer M, Schoelwer MJ, Bonner HG, Wakeman CA, Cherñavvsky DR, Gonder-Frederick L. Sleep and diabetes-specific psycho-behavioral outcomes of a new automated insulin delivery system in young children with type 1 diabetes and their parents. Pediatr Diabetes. 2021 May;22(3):495-502. doi: 10.1111/pedi.13164. Epub 2020 Dec 8. PMID: 33289242.

Sharifi A, De Bock MI, Jayawardene D, Loh MM, Horsburgh JC, Berthold CL, Paramalingam N, Bach LA, Colman PG, Davis EA, Grosman B, Hendrieckx C, Jenkins AJ, Kumareswaran K, Kurtz N, Kyoong A, MacIsaac RJ, Speight J, Trawley S, Ward GM, Roy A, Jones TW, O'Neal DN. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study. Diabetes Technol Ther. 2016 Dec;18(12):772-783. doi: 10.1089/dia.2016.0288. Epub 2016 Nov 11. PMID: 27835037.

McAuley SA, Lee MH, Paldus B, Vogrin S, de Bock MI, Abraham MB, Bach LA, Burt MG, Cohen ND, Colman PG, Davis EA, Hendrieckx C, Holmes-Walker DJ, Kaye J, Keech AC, Kumareswaran K, MacIsaac RJ, McCallum RW, Sims CM, Speight J, Stranks SN, Sundararajan V, Trawley S, Ward GM, Jenkins AJ, Jones TW, O'Neal DN; Australian JDRF Closed-Loop Research Group. Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial. Diabetes Care. 2020 Dec;43(12):3024-3033. doi: 10.2337/dc20-1447. Epub 2020 Oct 14. PMID: 33055139.

Cobry EC, Kanapka LG, Cengiz E, Carria L, Ekhlaspour L, Buckingham BA, Hood KK, Hsu LJ, Messer LH, Schoelwer MJ, Emory E, Ruedy KJ, Beck RW, Wadwa RP, Gonder-Frederick L; iDCL Trial Research Group. Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control. Diabetes Technol Ther. 2021 Jun;23(6):401-409. doi: 10.1089/dia.2020.0532. Epub 2021 Jan 28. PMID: 33404325; PMCID: PMC8215424.

Beato-Víbora PI, Gallego-Gamero F, Lázaro-Martín L, Romero-Pérez MDM, Arroyo-Díez FJ. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology. Diabetes Technol Ther. 2020 Dec;22(12):912-919. doi: 10.1089/dia.2019.0400. Epub 2020 Aug 28. PMID: 31855446.

Palmer W, Greeley SAW, Letourneau-Freiberg LR, Naylor RN. Using a Do-It-Yourself Artificial Pancreas: Perspectives from Patients and Diabetes Providers. J Diabetes Sci Technol. 2020 Sep;14(5):860-867. doi: 10.1177/1932296820942258. Epub 2020 Jul 17. PMID: 32680447; PMCID: PMC7753849.

Jordan E. Pinsker, Lars Müller, Alexandra Constantin, Scott Leas, Michelle Manning, Molly McElwee Malloy, Harsimran Singh, and Steph Habif.Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology.Diabetes Technology & Therapeutics.Feb 2021.120-127.http://doi.org/10.1089/dia.2020.0388

Barnard KD, Wysocki T, Thabit H, Evans ML, Amiel S, Heller S, Young A, Hovorka R; Angela Consortium. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting. Diabet Med. 2015 May;32(5):601-8. doi: 10.1111/dme.12706. Epub 2015 Feb 20. PMID: 25615888.

Cobry EC, Karami AJ, Meltzer LJ. Friend or Foe: a Narrative Review of the Impact of Diabetes Technology on Sleep. Curr Diab Rep. 2022 Jul;22(7):283-290. doi: 10.1007/s11892-022-01468-x. Epub 2022 May 6. PMID: 35522354.

Laiteerapong N, Ham SA, Gao Y, Moffet HH, Liu JY, Huang ES, Karter AJ. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care. 2019 Mar;42(3):416-426. doi: 10.2337/dc17-1144. Epub 2018 Aug 13. PMID: 30104301; PMCID: PMC6385699.

Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, McGill JB, Polonsky W, Price D, Aronoff S, Aronson R, Toschi E, Kollman C, Bergenstal R; DIAMOND Study Group. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial. Ann Intern Med. 2017 Sep 19;167(6):365-374. doi: 10.7326/M16-2855. Epub 2017 Aug 22. PMID: 28828487.

Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R, Schierloh U, Sulli N, Bolinder J; SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012 Dec;55(12):3155-62. doi: 10.1007/s00125-012-2708-9. Epub 2012 Sep 11. PMID: 22965294; PMCID: PMC3483098.

Qu Y, Jacober SJ, Zhang Q, Wolka LL, DeVries JH. Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data. Diabetes Technol Ther. 2012 Nov;14(11):1008-12. doi: 10.1089/dia.2012.0099. PMID: 23101951.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008 Oct 2;359(14):1464-76. doi: 10.1056/NEJMoa0805017. Epub 2008 Sep 8. PMID: 18779236.

Laffel LM, Kanapka LG, Beck RW, Bergamo K, Clements MA, Criego A, DeSalvo DJ, Goland R, Hood K, Liljenquist D, Messer LH, Monzavi R, Mouse TJ, Prahalad P, Sherr J, Simmons JH, Wadwa RP, Weinstock RS, Willi SM, Miller KM; CGM Intervention in Teens and Young Adults with T1D (CITY) Study Group; CDE10. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020 Jun 16;323(23):2388-2396. doi: 10.1001/jama.2020.6940. PMID: 32543683; PMCID: PMC7298603.

Maiorino MI, Signoriello S, Maio A, Chiodini P, Bellastella G, Scappaticcio L, Longo M, Giugliano D, Esposito K. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials. Diabetes Care. 2020 May;43(5):1146-1156. doi: 10.2337/dc19-1459. PMID: 32312858.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. PMID: 29162583; PMCID: PMC6467165.

Lin R, Brown F, James S, Jones J, Ekinci E. Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus. Diabet Med. 2021 May;38(5):e14528. doi: 10.1111/dme.14528. Epub 2021 Mar 6. PMID: 33496979

Hirsch IB. Professional flash continuous glucose monitoring as a supplement to A1C in primary care. Postgrad Med. 2017 Nov;129(8):781-790. doi: 10.1080/00325481.2017.1383137. Epub 2017 Oct 5. PMID: 28945141.

Jiao Y, Lin R, Hua X, Churilov L, Gaca MJ, James S, Clarke PM, O'Neal D, Ekinci EI. A systematic review: Cost-effectiveness of continuous glucose monitoring compared to self-monitoring of blood glucose in type 1 diabetes. Endocrinol Diabetes Metab. 2022 Nov;5(6):e369. doi: 10.1002/edm2.369. Epub 2022 Sep 16. PMID: 36112608; PMCID: PMC9659662.

Alva S, Bailey T, Brazg R, Budiman ES, Castorino K, Christiansen MP, Forlenza G, Kipnes M, Liljenquist DR, Liu H. Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes. J Diabetes Sci Technol. 2022 Jan;16(1):70-77. doi: 10.1177/1932296820958754. Epub 2020 Sep 19. PMID: 32954812; PMCID: PMC8875061.

Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S. The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System. Diabetes Technol Ther. 2015 Nov;17(11):787-94. doi: 10.1089/dia.2014.0378. Epub 2015 Jul 14. PMID: 26171659; PMCID: PMC4649725.

Zaharieva DP, Turksoy K, McGaugh SM, Pooni R, Vienneau T, Ly T, Riddell MC. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes. Diabetes Technol Ther. 2019 Jun;21(6):313-321. doi: 10.1089/dia.2018.0364. Epub 2019 May 6. PMID: 31059282; PMCID: PMC6551983.

Garg SK, Liljenquist D, Bode B, Christiansen MP, Bailey TS, Brazg RL, Denham DS, Chang AR, Akturk HK, Dehennis A, Tweden KS, Kaufman FR. Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study. Diabetes Technol Ther. 2022 Feb;24(2):84-92. doi: 10.1089/dia.2021.0182. Epub 2021 Sep 9. PMID: 34515521; PMCID: PMC8817689.

Wadwa RP, Laffel LM, Shah VN, Garg SK. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes. Diabetes Technol Ther. 2018 Jun;20(6):395-402. doi: 10.1089/dia.2018.0150. Epub 2018 Jun 14. PMID: 29901421; PMCID: PMC6110124.

Grosman B, Parikh N, Roy A, Lintereur L, Vigersky R, Cohen O, Rhinehart A. In Silico Evaluation of the Medtronic 780G System While Using the GS3 and Its Calibration-Free Successor, the G4S Sensor. Ann Biomed Eng. 2023 Jan;51(1):211-224. doi: 10.1007/s10439-022-03079-9. Epub 2022 Sep 20. PMID: 36125605.

Heinemann L, Kamann S. Adhesives Used for Diabetes Medical Devices: A Neglected Risk With Serious Consequences? J Diabetes Sci Technol. 2016 Nov 1;10(6):1211-1215. doi: 10.1177/1932296816662949. PMID: 27566734; PMCID: PMC5094339.

Messer LH, Berget C, Beatson C, Polsky S, Forlenza GP. Preserving Skin Integrity with Chronic Device Use in Diabetes. Diabetes Technol Ther. 2018 Jun;20(S2):S254-S264. doi: 10.1089/dia.2018.0080. PMID: 29916740; PMCID: PMC6011799.

American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019 Jan;42(Suppl 1):S61-S70. doi: 10.2337/dc19-S006. PMID: 30559232.

Edelman SV, Argento NB, Pettus J, Hirsch IB. Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring. Diabetes Care. 2018 Nov;41(11):2265-2274. doi: 10.2337/dc18-1150. PMID: 30348844.

Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L. Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care. 2017 Dec;40(12):1614-1621. doi: 10.2337/dci17-0043. Epub 2017 Oct 25. PMID: 29070577.

Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011 Jul 7;343:d3805. doi: 10.1136/bmj.d3805. PMID: 21737469; PMCID: PMC3131116.

Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med. 2012 Sep 4;157(5):336-47. doi: 10.7326/0003-4819-157-5-201209040-00508. PMID: 22777524.

Benkhadra K, Alahdab F, Tamhane S, Wang Z, Prokop LJ, Hirsch IB, Raccah D, Riveline JP, Kordonouri O, Murad MH. Real-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis. Clin Endocrinol (Oxf). 2017 Mar;86(3):354-360. doi: 10.1111/cen.13290. Epub 2017 Jan 16. PMID: 27978595.

Gandhi GY, Kovalaske M, Kudva Y, Walsh K, Elamin MB, Beers M, Coyle C, Goalen M, Murad MS, Erwin PJ, Corpus J, Montori VM, Murad MH. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol. 2011 Jul 1;5(4):952-65. doi: 10.1177/193229681100500419. PMID: 21880239; PMCID: PMC3192603.

Park C, Le QA. The Effectiveness of Continuous Glucose Monitoring in Patients with Type 2 Diabetes: A Systematic Review of Literature and Meta-analysis. Diabetes Technol Ther. 2018 Sep;20(9):613-621. doi: 10.1089/dia.2018.0177. Epub 2018 Aug 10. PMID: 30095980.

American Diabetes Association. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019 Jan;42(Suppl 1):S71-S80. doi: 10.2337/dc19-S007. PMID: 30559233.

American Diabetes Association. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 Jan;43(Suppl 1):S77-S88. doi: 10.2337/dc20-S007. Erratum in: Diabetes Care. 2020 Aug;43(8):1981. PMID: 31862750.

Downloads

Published

2023-08-01

How to Cite

1.
Ciechański M, Witkowska E, Ostańska A, Szafran A, Wiśniewska K, Piasek L, et al. Pros and cons of continous glucose monitoring. JMS [Internet]. 2023 Aug. 1 [cited 2024 Jun. 16];93(1):e873. Available from: https://jms.ump.edu.pl/index.php/JMS/article/view/873

Issue

Section

Review Papers
Received 2023-06-15
Accepted 2023-09-19
Published 2023-08-01